Abstract The authors describe an amperometric biosensor for the amino acid L-arginine (L-Arg). It is based on the use of a Nafion/Polyaniline (PANi) composite on a platinum screen-printed electrode (Pt-SPE) using a novel recombinant arginine deiminase isolated from Mycoplasma hominis. The protein was over-expressed, purified and employed as a biorecognition element of the sensor. Enzymatic hydrolysis of L-Arg leads to the formation of ammonium ions which diffuse into the Nafion/PANi layer and induce the electroreduction of PANi at a potential of −0.35 V (vs Ag/AgCl). L-Arg sensitivity is 684 ± 32 A·M −1 ·m −2 , and the apparent Michaelis-Menten constant
Introduction
L-Arginine is one of 20 amino acids found in proteins which play an important role in cellular metabolism. Its guanidine group contains five potential hydrogen bond donors that are positioned for favourable interactions with biological hydrogen bond acceptors [1] . It is dispensable in healthy individuals as it may be formed from other amino acids. However, in people, who are seriously ill or injured, higher quantities of L-Arginine are required, as the body may be unable to synthesise it in sufficient quantities [2] . Certain cancers may be auxotrophic for a particular amino acid, and amino acid deprivation is one approach used to treat these tumours. It has been suggested that arginine-degrading enzymes may be effective in the control of arginine-dependent cancers [3] . Therefore, it is important to provide a means of monitoring levels of this amino acid in biological liquids [4] , nutrition supplements and most recently, cosmetics, due to the widespread use of this molecule.
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A variety of detection procedures for L-Arginine analysis have been developed, most of which involve time-consuming, costly and complex techniques, such as high-performance liquid chromatography [5] . Other examples are methods based on spectrophotometry [6] , fluorometry [7] , atomic absorption spectrometry [8] , catalytic-thermometric titrametry [9] , capillary electrophoresis [10] , and enzymatic assays [11, 12] .
There is an ongoing demand for easy-to-use, cost effective and decentralised diagnostic tools for clinical practice. The construction of L-Arginine biosensors has already been reported and many of these are based on the use of bacterial cells [13] and enzymes [14] within a recognition layer. Earlier reports on enzyme-based L-Arginine sensors employed L-Arg oxidase co-immobilised with horseradish peroxidase on a screenprinted amperometric electrode [14, 15] . Others were based on co-immobilised arginase and urease on the surface of pHelectrode, ammonium-selective (ASE) electrodes and thin-film interdigitated conductometric electrode [16] [17] [18] [19] [20] . Most of these biosensors exhibited good selectivity and were responsive to the target analyte, though characterised by poor precision/ insufficient stability and low sensitivity.
Non-enzymatic approaches include the use of electrocatalytic materials e.g. Martinez-Perinan et al. [21] reported the electrochemical detection of L-Arginine, L-ornithine and Lcitrulline in urine and serum, based on the use of Ni(OH) 2 nanoparticle-modified carbon nanotubes as a HPLC electrochemical detector. However, this method was useful only for detection of a group of amino acids and was not found to be selective for L-Arginine.
Stasyuk et al. [22, 23] proposed a novel L-Arg-selective amperometric bi-enzyme sensor, based on recombinant human arginase I, commercial urease and Nafion/Polyaniline (PANi) modified platinum electrodes, with sensitivity of 110 A·M −1 ·m −2 and wide linear range 0.07-0.6 mM. However, the main drawback of this biosensor was the insufficient working and storage stability. When multiple reactions take place in the same biolayer, there are limitations in relation to the rate of reaction and stability [24] . L-Arginine can be degraded by several enzymes including arginine deiminase (ADI), which is now commercially available, but the price of highly purified enzyme is prohibitive. ADI has high affinity for arginine and catalyses the irreversible hydrolysis of arginine to citrulline and ammonia. ADI belongs to a newly classified superfamily of guanidinegroup-modifying enzymes [25] . ADI has been successfully utilised for fluorometric detection of L-Arg in beverages [12] . ADI extracted from Pseudomonas putida MTCC 1313 was employed as a recognition element for ASE-based sensor for detection in juices [26] . However, some inconsistencies in the analytical performance were reported.
Herein we report the construction of an original, sensitive, selective and stable amperometric biosensor for L-arginine determination. In order to realise this an ammonium-sensing PANi layer was electropolymerised via potential cycling on a Nafion-modified commercial platinum screen-printed electrode (Pt-SPE) as described previously [22, 27] . Subsequently, a novel recombinant arginine deiminase (ADI) from Mycoplasma hominis was deposited on the PANi/Nafion/Pt-SPE surface and a biorecognition membrane formed by cross-linking in saturated glutaraldehyde (GA) vapour (see scheme Fig. 1S ). The L-Arg biosensor was employed in quantitation studies of both pharmaceutical (food supplement) and plasma samples from 15 human volunteers.
Material and methods

Reagents
Arginine deiminase (EC 3.5.3.6) from Mycoplasma hominis with an activity of 30-35 U·mg −1 (K M = 0.35 mM) [28] was over-expressed and purified in our laboratory [28] . Hydrochloric acid, sodium chloride, NaH 2 PO 4 , Na 2 HPO 4 , 5% Nafion® perfluorinated resin solution, glutaraldehyde (GA) (50% w/v aqueous solution), ethanol, bovine serum albumin (fraction V, 96%), and γ-aminobutyric acid (GABA) were purchased from Sigma-Aldrich (Germany, www. sigmaaldrich.com). Aniline (99%) was purchased from Sigma-Aldrich (Germany) and redistilled before use (Important: only freshly prepared aniline should be used for electropolymerisation studies). L-Arginine monohydrochloride was purchased from Sigma Aldrich (Japan, www.sigmaaldrich.com), ammonium chloride and Llysine were obtained from Fluka (Germany, www. sigmaaldrich.com). All the chemicals and solvents used were of analytical-reagent grade and used without further purification. L-Arg containing pharmaceutical BAminoplazmal 10% E^was purchased from Mr. Braun Melsungen AG (Germany, www.bbraun.de). 20 mM phosphate buffer containing 20 mM sodium chloride (further referred to as PB) pH 7.4, was used as the supporting electrolyte during electrochemical measurements. All solutions were prepared using 18.2 MΩ·cm purified water produced using a Simplicity water purification system (Millipore, France). All glassware and polyethylene materials were rinsed with ultrapure water and dried before use.
Instrumentation
All biosensors employed a three-electrode screen-printed platform (DRP-C550, DropSens, Spain) with a platinum working electrode (4 mm diameter), a platinum counter and a Ag/AgCl reference electrode. Amperometric measurements were performed using a portable potentiostat (μStat 400, DropSens, Spain), controlled by DropView 2.0 software and used in accordance with the producer's guide. Amperometric detection was performed at −0.35 V vs. the Ag/AgCl reference electrode at room temperature in an open 3 mL vessel filled with 20 mM PB, pH 7.4 under vigorous stirring. Prior to use, the biosensors were soaked in PB for 30 min at room temperature and the sensor response to a particular substrate concentration was taken as an average of three measurements. The longterm stability of the biosensor was evaluated via repeated determination of the biosensor response every 3-4 days. In between testing the devices were stored in PB at 4°C.
Arginine deiminase over-expression and purification ADI expression, renaturation and purification were performed as reported previously with some modifications [28] . Cells of Escherichia coli BL21 (DE3) fhuA2 [lon] ompT gal (λ sBamHIo ΔEcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 Δnin5) [dcm] ΔhsdS [29] were transformed with plasmid pET3d-ADI. Transformants were selected on Luria-Bertani medium at 37°C supplemented with 18 g·L −1 of agar, 100 mg·L
of ampicillin, 0.2% of arginine and 0.5% of glucose. Selected transformants were employed to produce ADI using C-750501 medium supplemented with 1.25% glycerol and 0.01% lactose following autoinduction protocol modified earlier [28] . The induced cells were harvested by centrifugation (5000×g for 15 min at 4°C), washed with 20 mM sodium phosphate buffer, pH 7.2, and stored at −70°C. To obtain a suspension of ADI inclusion bodies the bacterial pellet was resuspended in 50 mM Tris-HCl buffer, pH 7.8 containing 1 mM EDTA and 0.2% lysozyme and treated as described earlier. The pellet containing ADI synthesised as inclusion bodies was washed with 20 mM sodium phosphate pH 7.2, 1 mM EDTA, 4% Triton X-100, re-pelleted and used for renaturation and purification of the enzyme as optimised previously [28] .
The solution of purified enzyme was concentrated using an ultrafiltration spin column (Vivaspin-Turbo 15, Sartorius Stedim Biotech GmbH, Germany), filter-sterilised using 0.22 μM filters (CE 0459 Millex-gv, Millipore, USA) and stored at 4°C. Protein concentration was determined by the Lowry method. ADI activity was determined as described previously [30] . One unit (U) of activity was defined as the amount of enzyme that converted 1 μmol L-arginine to Lcitrulline and ammonium per min at 37°C.
Electrode modification with PANi-Nafion composite
An aliquot (2 μL) of 2 wt% Nafion solution (prepared from 5% sample by 96% ethanol dilution) was deposited onto the surface of a Pt-SPE and air-dried for 15 min. The aniline polymerisation was performed using cyclic voltammetry in 0.2 M aniline solution in 0.5 M HCl by sweeping the potential between −0.4 V and 1.0 V (vs. Ag/AgCl) at a scan rate of 0.02 V·s − 1 at room temperature for 7 cycles. The
PANi/Nafion/Pt-SPE was rinsed thoroughly with distilled water and then dried in air for 15 min. All treatments and measurements were carried out at room temperature.
Enzyme immobilisation procedure
In order to prepare the L-Arg-selective membrane 18 µL of ADI solution (300 U·mL −1 in 1 M NaCl and 20 mM PB, pH 7.2) were mixed with 2 μL of 50% BSA in 20 mM PB, pH 7.2. 2 μL of this ADI-BSA solution was drop-cast onto the PANi/Nafion/Pt-SPE surface and incubated in saturated GA (25% w/v) vapour for the cross-linking for 35 min in an exhaust fume hood at room temperature. Prior to use, the bioelectrodes were dried for 1 h at 4°C, following which they were washed 3 times with 0.02 M PB, pH 7.4 to remove residual GA. The electrodes with bio-selective membranes were stored in 50 mM PB, pH 7.4 at 4°C until use (Fig. 1S) .
Preparation of real samples and standard addition assay PIRSES-GA-2012-318,053) were followed. This procedure was adhered to during collection, delivery and investigation of all human biological samples. Venous blood (2 mL) was collected in a heparinised cold tube. The tube was centrifuged at 1500 g for 10 min and cellfree supernatant removed. All plasma samples were kept cold in an ice box during the time between collection and biosensor measurement. L-Arg assay in the test samples was performed by means of amperometry at −0.35 V vs. Ag/AgCl using the standard addition method. An aliquot of the plasma sample was directly injected into the measuring vessel in order to obtain a 10-fold dilution. L-Arg concentration in human plasma samples were analysed by the DMO-based fluorometric enzymatic assay reported previously [11] , and used as a reference methodology.
Results and discussion
Modification of platinum screen printed electrodes with Nafion/PANi Prior to PANi deposition via electropolymerisation, the Pt-SPE working electrode surface was modified with Nafion (2% in EtOH), sulphonated tetrafluoroethylene polymer. The acidic groups on the surface of the polymer acted as charge compensator in the course of anodic polymerisation of aniline [31] . Following the drying step at room temperature, the electropolymerisation of aniline took place as per procedure 2.4 (see Fig. 2S for growth cycles), following optimisation of potential limits, scan rate and cycle number.
The profiles of cyclic voltammograms carried out during the electrodeposition of PANi onto Nafion/Pt-SPE differed slightly with respect to those reported in the literature [22, 23] . The difference results in a ca. 0.15 V cathodic shift for the arising peaks taking into consideration the screenprinted reference electrode. The anodic scan of the first cycle was characterised by a large peak of monomer oxidation at 0.9 V. The backward scan was characterised by a nucleation loop, probably due to the new phase formation, followed by a broad cathodic wave. Upon further cycling, the monomer oxidation peak decreased with simultaneous growth of two redox processes at 0-0.15 V (emeraldine) and 0.5-0.65 V (pernigraniline), confirming the typical redox characteristics of polyaniline films which were additionally indicated visually by the colour change to dark green of the ermeraldine (half oxidised form).
Electrochemical properties of Nafion/PANi-modified electrode towards ammonium ions
The electrochemical properties of Nafion/PANi-modified electrode were examined using cyclic voltammetry at pH 7.4 (Fig. 1a) . The addition of NH 4 Cl to the solution led to the appearance of a voltammetric response in the form of increased cathodic currents (−0.2 to −0.4 V).
Ammonium ions which diffused to the Nafion/PANi layer provoked the reduction of PANi on Pt-SPE to the leucoemeraldine form. If the PANi/Nafion composite is polarised at a reduction potential, the cathodic response is proportional to the ammonium ion concentration in the solution [32] .
In order to determine the optimal polarisation voltage for amperometric detection, ammonium ion assays at a range of applied potentials (−0.2 to −0.4 V) were carried out with the current maximum found at −0.35 V (Fig. 3S) . Hydrodynamic data for the PANi/Nafion/Pt-SPE is shown in (Fig. 1b) , and exhibited a consistent increase in the steady state cathodic current in response to increased ammonium ion concentration. Under the same conditions, PANi/Nafion/Pt-SPE was completely insensitive to L-Arg (Fig. 2b) . The resultant calibration curve exhibited a linear range from 0.003 to 0.2 mM and a sensitivity value within the linear range of 701 ± 33 A· M −1 ·m −2 (Fig. 1c) . The limit of detection (LOD) calculated as 3 × SD was 1 μM NH 4 Cl.
Immobilisation of ADI and biosensor performance in model media (PB pH 7.4)
ADI was immobilised on PANi/Nafion/Pt-SPE by crosslinking with BSA in saturated GA vapour according to experimental BEnzyme immobilisation procedure^section. The presence of BSA ensured a high operational stability due to ideal conditions for retaining the maximal enzyme activity. The pH optimum resulting in highest activity for the sensor was 7.2 in 20 mM PB (Fig. 4S) , which is compatible with the requirements for physiological testing. These conditions were employed for further L-Arg assays. Voltammetric studies of ADI/PANi/Nafion/Pt-SPE are shown in Fig. 2a . The addition of L-Arg into the cell resulted in a significant increase in the cathodic current at potentials between −0.2 and −0.4 V (vs. Ag/AgCl).
The CV results and previous ammonium ion detection data indicated that −0.35 V was a suitable applied potential for the detection of L-Arg. In Fig. 2b , the amperometric responses of the L-Arg biosensor are reported showing a consistent increase in the cathodic current as a result of increasing LArg concentration. The calibration curve is shown in Fig. 2c . The dynamic range was linear between 0.003 and 0.2 mM LArg (Fig. 2d) . The K M app derived from the Lineweaver-Burk plot was 0.31 ± 0.05 mM for L-Arg. This value is practically the same as that for ADI in solution (0.35 mM [28] ). The sensitivity was calculated as 684 ± 32 A·M
, LOD was 1 μM and the response time was 15 s.
The efficacy of the ADI reaction was calculated from the I steady-state /2 values, presented in the graphs in Fig. 1c and Fig. 2c . The similarity of the calibration curves for detection of both ammonium ions and L-Arg indicates that the conversion rate of L-Arg to citrulline and ammonium ion was 97.6%. In addition, the almost ideal L-Arg conversion rate means that the procedure chosen for ADI immobilisation on the Nafion/ PANi/Pt-SPE was the most enzyme-friendly one (i.e. the active sites, conformation and catalytic activity of the ADI were not altered significantly during the immobilisation procedure).
The stability of ADI/PANi/Nafion/Pt-SPE was explored by monitoring its response to the injection of a 0.2 mM L-Arg standard solution over a period of 35 days. The biosensor preserved around 93% (SD = 6.5%) stability after 35 days storage or following 100 assays (Fig. 6S) .
The comparison of the analytical performance of the LArg-selective biosensor with the analytical parameters of systems described in the literature (Table 1) shows that the biosensor realised here has advantageous characteristics, yielding one of the lowest limits of detection together with high sensitivity, wide linear range and long-term stability, thus making it potentially suitable for clinical sample analysis for the L-Arg levels of humans (60-100 μM in blood [33] ).
The effects of some possible interfering amino acids (Ile, Lys, Thr, Orn, Ser, Val, Cys, GABA and citrulline) on the PANi/Nafion/Pt-SPE composite were investigated and the presence of amino acids in PB showed negligible response (significance level less than 5%) (Fig. 5S) .
It was reported earlier, that canavanine, the substrate of arginase I, is hydrolysed by ADI and induces an analytical signal [34] . However, an impact of canavanine on the L-Arg assay is not important due to the rare presence of this compound in biological fluids (blood, serum/plasma and urine).
Notably, an addition of highly concentrated solutions of chloride salts (over 50 mM, Fig. 7S ) causes a decrease in the current due to a potential shift at the internal open Ag reference electrode of the biosensor, which coincides well with the results obtained by Strehlitz et al. [32] .
L-Arg assay in pharmaceutical and human plasma samples
In order to demonstrate feasibility of the L-Arg biosensor for the assessment of target analyte concentrations in real samples, some L-Arg-containing pharmaceutical and human plasma samples were collected and analysed. The results were compared with the L-Arg content estimated by the reference method (DMO-based fluorometric enzymatic method [11] (Table 2) .
L-Arg assay in commercial pharmaceutical samples was performed by amperometric detection using a portable potentiostat (μStat 400), following the standard addition method (Fig. 3) .
In our study BAminoplazmal 10% E^, an L-Arg-containing pharmaceutical was tested as it represents one of the most interesting L-Arg-containing commercially available samples (according to the manufacturer's certificate, this pharmaceutical contains a number of amino acids and other additives). The results of L-Arg assay in the BAminoplazmal 10% E^using the biosensor were compared with those declared by manufacturer and only slight differences were observed (RSD is less than 2.5% for n = 3) (Fig. 3) . The L-Arg biosensor was also tested for the L-Arg quantification in plasma samples of healthy donors and patients with hepatic disorder using the standard addition method (RSD -14% for n = 3). Due to the fact that in serum/plasma of healthy humans the concentrations of L-Arg and endogenous ammonium ions are very close (60-100 μM [33] and 20-50 μM [35] , respectively), the latter was additionally measured in plasma samples with the PANi/Nafion/Pt-SPE. A concentration of L-Arg in plasma was calculated as a difference between the signals of ADI/PANi/Nafion/Pt-SPE-and PANi/Nafion/Pt-SPE -based sensors.
The data presented showed a strong correlation with the reference method for L-Arg measurement based on fluorometry with an RSD of 10%. The L-Arg concentration in plasma of healthy donors was 1.5-2 times lower than in plasma of patients with hepatic disorder. The results of L-Arg assays, presented in Table 2 , are close to previously reported values for healthy adults [4, 33] and patients with hepatic disorder [36] . These results indicate that the L-Arg biosensor presented here can be exploited for fast and effective assay of L-Arg in simple (pharmaceuticals) and complex (human plasma) media.
Conclusions
An amperometric L-Arg biosensor based on recombinant ADI has been developed and optimised for the first time. The biosensor is characterised by a low applied potential (−0. ), a low limit of detection (0.001 mM) and good storage stability (>35 days). The L-Arg amperometric biosensor facilitated facile analysis of real samples; there was no need for complex sample pretreatment (except sample dilution) due to the one-step L-Arg transformation by arginine deiminase. This performance cannot be achieved for bi-enzyme (arginase and urease) and for mono-enzyme (inhibitory urease) sensor formats reported previously as they will always suffer from the necessity to eliminate the endogenous urea in plasma, blood and urine samples). Measurements in real samples (pharmaceutical and human plasma) proved to be in a good agreement with reference fluorometric enzymatic assay (RSD do not exceed 10%).
